Glyn Edwards MBE Joins OxSonics’ Board as Non-Executive Director

Oxford, UK – 25th October 2017 – OxSonics Limited, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer patients, today announced that Glyn Edwards is to join the board as Non-Executive Director. Glyn Edwards has held the position of CEO of Summit plc since April 2012 where he […]

OxSonics Expands Operations In Oxford

Oxford, UK – 26 September 2017 – OxSonics Limited, today announced it has expanded its operations in Oxford and moved into newly developed state of the art laboratories and offices. The newly customized facilities occupy the entire East wing of the second floor of the  “Magdalen Centre North” building and spans over 4,800 square feet. […]

OxSonics Limited A Finalist For “Best Emerging UK Medtech Company” Award

Oxford, UK – 1 September 2017 – OBN Ltd, the membership organisation supporting the UK’s innovative life sciences companies has announced the finalists of its 8th Annual Awards covering Biotech, Medtech, Synthetic Biology and Digital Health. The OBN Awards remain proudly independent, celebrating innovation and achievement across the UK life sciences industry and recognising achievements […]

OxSonics and OrthoSon Raise Over £9.4m in Series B Equity Financing

Oxford, UK – 9th January 2017 – OxSonics® Limited today announced that over £9.4 million of Series B equity financing had been successfully raised. The funding was provided by a combination of new and existing investors, including Longwall Venture Partners, Oxford Technology Innovation EIS Fund, the University of Oxford, Winton Ventures, Perivoli Innovations as well […]